Los puntos clave no están disponibles para este artículo en este momento.
B7-H3, a protein expressed on the surface of the most lethal prostate cancers, in particular those with specific mutations, can be targeted using drugs that bind B7-H3. These findings are relevant for the development of such drugs and for deciding which patients to treat with these new drugs.
Guo et al. (Tue,) studied this question.